These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24296419)

  • 1. Metabolomics and transcriptomics demonstrate severe oxidative stress in both localized chemotherapy-treated and bystander tumors.
    Morvan D; Demidem A
    Biochim Biophys Acta; 2014 Mar; 1840(3):1092-104. PubMed ID: 24296419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced bystander effect in response to several chloroethylnitrosoureas: an origin independent of DNA damage?
    Merle P; Morvan D; Caillaud D; Demidem A
    Anticancer Res; 2008; 28(1A):21-7. PubMed ID: 18383820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CENU treatment induced bystander effects which are effective on parental and non-parental tumors and have a phospholipid metabolism proton NMR spectroscopy signature.
    Merle P; Morvan D; Madelmont JC; Caillaud D; Demidem A
    Int J Oncol; 2006 Sep; 29(3):637-42. PubMed ID: 16865279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in mice.
    Soucek J; Poucková P; Zadinová M; Hlousková D; Plocová D; Strohalm J; Hrkal Z; Oleár T; Ulbrich K
    Neoplasma; 2001; 48(2):127-32. PubMed ID: 11478693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells: a relay for chemotherapy?
    Demidem A; Morvan D; Madelmont JC
    Int J Cancer; 2006 Sep; 119(5):992-1004. PubMed ID: 16557598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal role of oxidative stress in tumor metastasis under diabetic conditions in mice.
    Ikemura M; Nishikawa M; Kusamori K; Fukuoka M; Yamashita F; Hashida M
    J Control Release; 2013 Sep; 170(2):191-7. PubMed ID: 23735571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways.
    Morvan D; Demidem A
    Cancer Res; 2007 Mar; 67(5):2150-9. PubMed ID: 17332345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.
    Guénin S; Morvan D; Thivat E; Stepien G; Demidem A
    Nutr Cancer; 2009; 61(4):518-29. PubMed ID: 19838924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interleukin-1 receptor antagonist and chemotherapy on host-tumor interactions in established melanoma.
    Triozzi PL; Aldrich W
    Anticancer Res; 2010 Feb; 30(2):345-54. PubMed ID: 20332438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
    Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
    Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary study on molecular mechanism of curcumine anti-mouse melanoma].
    Gui F; Ma WF; Cai SH; Li XK; Tan Y; Zhou CL; Chen HY
    Zhong Yao Cai; 2008 Nov; 31(11):1685-9. PubMed ID: 19260281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells.
    Youn MJ; Kim JK; Park SY; Kim Y; Park C; Kim ES; Park KI; So HS; Park R
    J Ethnopharmacol; 2009 Jan; 121(2):221-8. PubMed ID: 19041933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress.
    Baldi A; Lombardi D; Russo P; Palescandolo E; De Luca A; Santini D; Baldi F; Rossiello L; Dell'Anna ML; Mastrofrancesco A; Maresca V; Flori E; Natali PG; Picardo M; Paggi MG
    Clin Cancer Res; 2005 May; 11(9):3175-83. PubMed ID: 15867210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature.
    Anasagasti MJ; Martin JJ; Mendoza L; Obrador E; Estrela JM; McCuskey RS; Vidal-Vanaclocha F
    Hepatology; 1998 May; 27(5):1249-56. PubMed ID: 9581678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis.
    Costantino VV; Lobos-Gonzalez L; Ibañez J; Fernandez D; Cuello-Carrión FD; Valenzuela MA; Barbieri MA; Semino SN; Jahn GA; Quest AF; Lopez LA
    Cancer Lett; 2016 Mar; 372(1):10-23. PubMed ID: 26718258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.
    Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
    J Invest Dermatol; 2000 Dec; 115(6):1059-64. PubMed ID: 11121142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
    Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
    Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell growth in vitro and in vivo.
    Liu KS; Ding WC; Wang SX; Liu Z; Xing GW; Wang Y; Wang YF
    Oncol Rep; 2012 Jun; 27(6):1904-10. PubMed ID: 22447251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.